Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
Spero Therapeutics: The Multi-Asset Pipeline Could Outpace The Tebipenem HBr Deal With GSK
03:06pm, Wednesday, 05'th Jul 2023
Spero is eligible to receive up to $525 million in development and sales milestone payments as well as royalties on net product sales under the agreement with GSK. In addition, Spero has two other ass
GSK-spinoff Haleon exploring sale of Nicotine gum business - Bloomberg News
12:35pm, Monday, 03'rd Jul 2023
Haleon , the world's biggest standalone consumer health business, is exploring the sale of its nicotine gum business as it aims to streamline its business, Bloomberg News reported on Monday, citing pe
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
08:46am, Thursday, 29'th Jun 2023
The CDC said the shots from Pfizer and GSK are expected to be available this fall, when RSV – along with Covid and the flu – begins to spread at higher levels.
US CDC recommends use of new Pfizer, GSK vaccines for RSV in older adults
08:43am, Thursday, 29'th Jun 2023
The director of the U.S. Centers for Disease Control and Prevention (CDC) signed off on Thursday on the use of new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infe
Better Artificial Intelligence Stock: GSK or Eli Lilly?
03:15pm, Wednesday, 28'th Jun 2023
Artificial intelligence is being used by the world's top drugmakers to speed up innovation in areas of high unmet medical need. GSK and Eli Lilly are both pioneers in the use of AI for drug discovery
Drugmaker GSK Is Becoming a Healthier Value Stock
11:44am, Tuesday, 27'th Jun 2023
Like most stocks during the dot-com bubble, GSK PLC NYSE: GSK partied like it was 1999. In the two decades since, missteps and competitive pressures slashed roughly 50% from the U.K. pharmaceutical
GSK achieves fast-track Status from US regulator for groundbreaking gonorrhoea vaccine
03:24am, Tuesday, 27'th Jun 2023
GSK PLC (LSE:GSK, NYSE:GSK) has received fast-track designation from the US Food and Drug Administration (FDA) for its experimental vaccine against Neisseria gonorrhoeae, the bacteria causing gonorr
GSK's gonorrhoea vaccine receives FDA's 'fast-track' designation
03:15am, Tuesday, 27'th Jun 2023
GSK's vaccine candidate to treat sexually transmitted infection gonorrhoea has been granted a fast-track designation by the U.S. Food and Drug Administration (FDA), the British drugmaker said on Tuesd
Is GSK PLC Sponsored ADR (GSK) Stock Outpacing Its Medical Peers This Year?
11:16am, Monday, 26'th Jun 2023
Here is how GSK (GSK) and Ligand Pharmaceuticals (LGND) have performed compared to their sector so far this year.
Is GSK a Strong Buy Right Now?
09:45am, Monday, 26'th Jun 2023
GSK has underperformed the broader markets and most of its big pharma peers over the last 10 years. With a tighter focus on branded pharma products, GSK arguably deserves another look by investors.
GSK settlement clears much if the the Zantac liability 'overhang', says US bank
09:19am, Monday, 26'th Jun 2023
GSK PLC (LSE:GSK, NYSE:GSK)'s settlement with a California plaintiff over an alleged link between Zantac and cancer "clears 80%+ of the liability overhang", according to Jefferies. However, the US in
GSK: A Biopharma Giant On Sale
02:36am, Saturday, 24'th Jun 2023
GSK, or GlaxoSmithKline, has performed badly in the past decade, but its future outlook may not be as bleak. The company has spun off its consumer healthcare segment to focus on the vaccine and HIV se
GSK Settles Zantac Cancer Lawsuit Set to Go to Trial Next Month
04:30pm, Friday, 23'rd Jun 2023
American depositary receipts of GSK jumped after the U.K.-based biopharma company said it had reached a settlement in a lawsuit accusing the firm's discontinued heartburn medicine, Zantac, of causing
2 Stocks Defying Friday's Market Downturn
09:37am, Friday, 23'rd Jun 2023
Markets opened lower on Friday. CarMax reported weak financial results that were nevertheless better than most investors had expected.
GSK out-of-court deal encouraging but 'not the final full stop' in Zantac saga, say analysts
08:17am, Friday, 23'rd Jun 2023
GSK PLC (LSE:GSK, NYSE:GSK) making an out-of-court settlement for a case in California alleging its Zantac heartburn medication caused cancer, is "not a full stop" for the saga, say analysts. Paying
